Financing: troubled Polish drugmaker Bioton said it would receive a total of 171 million zlotys ($48.8 million) capital injection from its main shareholder and his investment arm, boosting its shares.
Cyprus-based Bithell Holding, which Bioton said was linked to Poland's richest man Zygmunt Solorz-Zak, agreed last month to invest 70 million. Solorz-Zak holds 10% of the drugmaker. ($1 = 3.506 Zloty)
|Printer friendly Cite/link Email Feedback|
|Title Annotation:||WALL ST./FINANCE|
|Article Type:||Brief article|
|Date:||Apr 6, 2009|
|Previous Article:||Markets: not even mind-numbing March job losses could get in the stock market's way Friday.|
|Next Article:||Weekly key rates.|